IRCT201109067483N1已完成未知
The effect of adding Spironolactone to Enalapril therapy on micro albuminuria due to diabetes.
Qazvin Metabolic Diseases Research Centre(QMDRC), Qazvin university of medical sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Diabetic nephropathy as micro-albuminuria, More than 18 years old, Less than 80 years old
- •Exclusion criteria: Serum creatinine more than 2mg/dl, Serum Potassium more than 5.5 mmol/dl at any stage of the study, Cardiac ejection fraction less than 35%
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Comparison between the effects of spironolactone and eplerenone in the treatment of heart failureIRCT20130422013090N4Sari University of Medical Sciences70
招募中
3 期
The effect of spironolactone as adjunctive therapy on the improvement of cognitive symptoms and maniaBipolar disorderIRCT20190316043072N2Karaj University of Medical Sciences60
已完成
2 期
Comparative study between Spironolactone vs Eplerenonein patients undergoing revascularization with acute myocardial infarction having LV dysfunctioCTRI/2021/10/037504AIIMS BHUBANESWAR88
已完成
2 期
The Effect of Spironolactone in Treatment of Essential HypertensioHypertension.Essential (primary) hypertensionIRCT201502011525N6Shiraz University of Midical Sciences40
已完成
3 期
The Efficacy of Spironolactone in Continuous Ambulatory Peritoneal Dialysis Patients with Hypokalemia: A Randomized Controlled TrialA randomized controlled trial was conducted in CAPD patients with serum potassium <3.5 mEq/L.End stage renal disease,Hypokalemia,Peritoneal dialysis,SpironolactoneTCTR20200818005one50